Views
4 years ago

114 - D Cohen - Junio 2019

  • Text
  • Corticolimbicos
  • Emergentes
  • Neurobiologia
  • Limite
  • Psico
  • Amyg
  • Trastorno
  • Conductas
  • Nivel
  • Psychiatry
  • Procesamiento
  • Corteza
  • Estudios
  • Borderline
  • Pacientes
De la neurobiología a la clínica: una visión desde la integración de niveles de las dimensiones del trastorno límite de la personalidad

Dr. Diego

Dr. Diego Cohen chotic reactivity in borderline personality disorder. Acta Psych Scand 2010; 121(2): 125-134. • Eisenberger NJ. The neural basis of social pain: Findings and implications. En: MacDonald G, Jensen-Campbell LA. Social pain: neuropsychological and health implications of loss and exclusion. Washington DC: American Psychological Association; 2011. p. 53-78. • Eisenberger NJ. The pain of social disconnection: examining the shares neural underpinnings of physical and social pain. Nat Rev Neurosci 2012; 13(6): 421-434. • Ellison W, Rosenstein L, Morgan T, Zimmerman M. Community and clinical epidemiology of borderline personality disorder. Psychiatr Clin North Am 2018;41(4): 561-573. • Etkin A, Büchel C, Gross J. The neural bases of emotion regulation. Nat Rev Neurosci 2015; 16 (11):693-700. • Fonagy P, Bateman A. The devolpment of borderline personality disorder- a mentalizing model. J Pers Disord 2008; 22(1): 4–21. • Fossati A, Barratt E, Borroni S, Villa D, Grazioli F, Maffei C. Impulsivity, aggressiveness, and DSM-IV personality disorders. Psychiatry Research 2007; 149 (1-3): 157-167. • Gilbertson MW, Shenton ME, Ciszewski A, Kasai K, Lasko NB, Orr SP, Pitman RK. Smaller hippocampal volume predicts pathological vulnerability to psychological trauma. Nat Neurosci 2002; 5(11): 1242–7. • Glaser J, Van Os J, Thewissen V, Myin-Germeys I. Psychotic reactivity in borderline personality disorder. Acta Psychiatrica Scandinavica 2010; 121(2): 125-134. • Goyer PF, Andreason PJ, Semple WE, Clayton AH, King AC, Compton-Toth BA, Schulz SC, Cohen RM. Positron-emissiontomography and personality disorders. Neuropsychopharmacology 1994; 10(1):21–8. • Grant BG, Chou PS, Goldstein RB, Boji MPH, Stinson FS, Saha T, Smith SM et al. Prevalence, correlates, Disability, and Comorbidity of DSM-IV borderline personality disorder: results from the wave 2 national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 2008; 69(4): 533–545. • Grant J, Correia S, Brennan-Krohn T, Malloy P, Laidlaw D, Schulz S. Frontal white matter integrity in borderline personality disorder with self-injurious behavior. J Neuropsychiatry Clin Neurosci 2007; 19(4): 383-390. • Gross R, Olfson M, Gameroff M, Shea S, Feder A, Fuentes M, Lantigua R, Weissman MM. Borderline personality disorder in primary care. Arch Intern Med 2002; 162(1): 53-60. Gunderson J, Lyons-Ruth K. BPD’s interpersonal hypersensitivity phenotype: a gene-environment-developmental model. J Pers Disord 2008; 22(1): 22-41. • Gunderson J. The emergence of a generalist model to meet public health needs for patients with borderline personality disorders. Am J Psychiatry 2016; 173(5): 452-458. • Gunderson J. Weinberg I. Choi-Kain L. Borderline personality disorder. Focus 2013; XI (2): 129-145. • Gunderson J, Herpertz S, Skodol A, Torgersen S, Zanarini M. Borderline personality disorder. Nat Rev Dis Primer 2018; 24 (4): 1–20. • Gunderson J, Choi-Kain L. Medication management for patients with borderline personality disorder. Am J Psychiatry 2018;175(8): 709-711. • Gurvits TV, Shenton ME, Hokama H, Ohta H, Lasko NB, Gilbertson MW, Orr SP, Kikinis R, Jolez FA, McCarley RW, Pitman RK. Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder. Biol Psychiatry 1996; 40 (11):1091–1099. • Hobson R, Patrick M, Hobson J, Crandell L, Bronfman E, Lyons-Ruth K. How mothers with borderline personality disorder relate to their year-old infants. Br J Psychiatry 2009; 195(4): 325-330. • Ingenhoven T, Lafay P, Rinne T, Passchier J, Duivenvoorden H. Effectiveness of pharmacotherapy for severe personality disorders. J Clin Psychiatry 2010; 71(1): 14-25. • Insel TR, Cuthbert, B. et al. Research Domain Criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry 2010; 167: 748-751. • Insel TR, Young L. The neurobiology of attachment. Nat Rev Neurosciens 2001; 2(2): 129-136. • Juengling F, Schmahl C, Heßlinger B, Ebert D, Bremner J, Gostomzyk J et al. Positron emission tomography in female patients with Borderline personality disorder. J Psychiatr Res 2003; 37(2): 109-115. • King-Casas B, Sharp C, Lomax-Bream L, Lohrenz T, Fonagy P, Montague PR. The rupture and repair of cooperation in borderline personality disorder. Science 2008; 321(5890); 806–810. doi:10.1126/ science.1156902. • Leyton M, Okazawa H, Diksic M, Paris J, Rosa P, Mzengeza S, Young SN, Blier P. Benkelfat C. Brain regional α-[11C] methyl-l-tryptophan trapping in impulsive subjects with borderline personality disorder. Am J Psychiatry 2001; 158(5):775-782. • Livesley JW, Jang KL, Jakcson DN, Vernon PA. Genetic and environmental contribution to dimensions of personality disorder. American J Psych 1993; 150 (12): 1825-1831. • Kendler KS, Aggen SH, Czajkowski N, Røysamb E, Tambs K, Torgersen S, Neale M, Reichbor – Kjennerud T. The structure of genetic and environmental risk factors for DSM-IV Personality Disorders. Arch Gen Psychiatry 2008; 65(12): 1438-1446. • LeDoux J. The synaptic self. New York: Penguin Books; 2002. • LeDoux J. The emotional brain. Enskede: TPB; 2008. • Lenzenweger MF. Current status of the scientific study of personality disorders: an overview of epidemiological, longitudinal, experimental psychopathology and neurobehavioral perspectives. J Am Psychoanal Assoc 2010; 58 (4): 741–778. • Lis E, Greenfield B, Henry M, Guilé JM, Doughert J. Neuroimaging and genetics of borderline personality disorder: a review. J Psychiatry Neurosci 2007; 32(3): 162-73. • Lucas P, Gardner D, Cowdry R, Pickar D. Cerebral structure in borderline personality disorder. Psychiatry Res 1989; 27(2): 111-115. • Lyons-Ruth K, Holmes BM, Sasvari-Szekel M , Zsolt R, Nemoda Z, Pauls, D. Serotonin transporter polymorphism and borderline/antisocial traits among low-income young adults. Psychiatr Genet 2007; 17(6): 339–343. • Lyoo I, Han M, Cho D. A brain MRI study in subjects with borderline personality disorder. J Affect Disord 1998; 50(2- 3):235-243. • Mega MS, Cummings JL, Salloway S, Malloy, P. The Limbic System: an anatomic, phylogenetic, and clinical perspective. J Neuropsychiatry Clin Neurosci 1997; 9 (3): 315-330. • McCrae R, Costa P. Personality in adulthood. New York: Guilford Press; 2006. • Mann JJ. Neurobiology of suicidal behaviour. Nat Rev Neurosci 2003; 4(10): 819-828. • Mateu G, Haro L, Revert A, Barabash A, Benito M, Traver CF. The role of genetics in the personality and its disorders: a clinical point of view. Actas Esp Psiquiatr 2008; 36(4):230-243. • Mehta M, Golembo N, Nosarti C, Colvert E, Mota A, Williams SC, Rutter M. Sonuga-Barke EJ. Amygdala, hippocampal and corpus callosum size following severe early institutional deprivation: The English and Romanian Adoptees Study Pilot. J Child Psychol Psychiatr 2009; 50 (8): 943-951. • Miller Bl, Cummings JL. The human frontal lobes. 2nd edition. New York: The Guilford Press; 2007. • Morris J, Friston KJ, Buchel C, Frith CD, Young AW, Calder AJ, Dolan RJ. A neuromodulatory role for the human amygdala in processing emotional facial expressions. Brain 1998; 121(1): 47-57. • Niedtfeld I, Kirsch P, Schulze L, Herpertz, S, Bohus M, Schmahl C. Functional Connectivity of Pain-Mediated Affect Regulation in Borderline Personality Disorder. PLoS One 2012; 7(3): 1-9 • New AS, Hazlett E, Buchsbaum M, Goodman M, Mitelman S, Newmark R, Trisdorfer R, Haznedar MM, Koenigsberg HW, Flory J, Siever LJ. Amygdala–prefrontal disconnection in borderline personality disorder. Neuropsychopharmacology 2007; 32 (7): 1629-1640. • Nigg JT, Goldsmith HH. Genetics of personality disorders: perspectives from personality and psychopatological research. Psychol Bull 1994; 115 (3): 346-80. • Ophir AG. Navigating monogamy: nonapeptide sensitivity in a memory neural circuit may shape social behavior and mating decisions. Front. Neurosci 2017; 11 (397): 1-16. • Otte C, Gold S, Penninx B, Pariante C, Etkin A, Fava M, Mohr DC, Schatzberg AF. Major depressive disorder. Nat Rev Dis Primers 2016; 15(2): 1-20. • Panksepp J, Herman B, Conner R, Bishop P, Scott JP. The biology of social attachments: opiates alleviates separation distress. Biol Psychiatry 1978; 13(5): 607-618. • Panksepp J. Affective Neuroscience: The Foundations of Human and Animal Emotions. New York: Oxford University Press; 1998. • Paris J. Understanding self-mutilation in borderline personality disorder. Harvard Rev Psych 2005; 13(3): 179-185. • Reitz S, Kluetsch R, Niedtfeld I, Knorz T, Lis S, Paret C, Kirsch P, Meyer – Lindenberg A, Treede RD, Baumgärtner U, Bohus M, Schmahl. Incision and stress regulation in borderline personality disorder: Neurobiological mechanisms of self-injurious behaviour. British J Psychiatry 2015; 207(2): 165-172. • Ruocco AC, Amirthavasagam S, Choi-Kain lW, McMain SF. Neural correlates of negative emotionality in borderline personality disorder: An activation-likelihood-estimation meta-analysis. Biol Psychiatry 2013; 73 (2): 153–160. • Schmahl CG, Vermetten E, Elzinga BM, Bremner JD. Magnetic resonance imaging of hippocampal and amygdala volume in women with childhood abuse and borderline personality disorder. Psychiatry Res 2003; 122: 109–15. • Schmahl Ch, Bremner JD. Neuroimaging in borderline personality disorder. J Psychiatr Res 2006; 40 (5): 419-427. • Silbersweig D, Clarkin J, Goldstein M, Kernberg O, Tuescher O, Levy KN, Brendel G, Pan H, Beutel M, Pavony MT, Epstein J, Lenzenweger MF, Thomas KM, Posner MI, Stern E. Failure of frontolimbic inhibitory function in the context of negative emotion in borderline personality disorder. Am J Psychiatry 2007; 164(12): 1832-1841. • Skodol AE, Siever L, Livesley WJ, Gunderson J, Pfohl B, Widiger T. The borderline diagnosis II: biology, genetics and clinical course. Biol Psychiatry 2002; 51: 951-963. • Siever LJ, Torgersen S, Gunderson JG, Livesley JW, Kendler KS. The borderline diagnosis III: identifying endophenotypes for genetic studies. Biol Psychiatry 2002; 51(12): 964–968. • Siever LJ: Opioid receptor and oxytocin genotypes in BPD. Annual Meeting Syllabus and Proceedings Summary. Washington, DC, American Psychiatric Association, 2009. • Silbersweig D, Clarkin JF, Goldstein M, Kernberg OF, Tuescher O, Levy KN, Brendel G, Pan H, Beutel M, Pavony MT, Epstein J, Lenzenweger MF, Thomas KM, Posner MI, Stern E. Failure of frontolimbic inhinitory function in the context of negative emotion in borderline personality disorder. Am J Psychiatry 2007; 164 (12): 1832-1841. • Silk KR, Lee S, Hill E, Lhor NE. Borderline personality disorder and severity of sexual abuse. Am J Psych 1995; 152(7): 1059-1064. • Stanley B, Siever LJ. The Interpersonal dimension of borderline personality disorder: toward a neuropeptide model. Am J Psych 2010; 167(1): 24-39. • Stanley B, Sher L, Wilson S, Eckman R, Huang Y, Mann JJ: Nonsuicidal self-injurious behavior, endogenous opioids, and monoamine neurotransmitters. J Affect Disord 2010; 124(1- 2): 134–140. • Stanley B, Perez-Rodriguez M, Labouliere C, Roose S. A Neuroscience-oriented research approach to borderline personality disorder. J Pers Disord 2018;22: 1-39. • Stoffers J, Völlm B, Rücker G, Timmer A, Huband N, Lieb K. Pharmacological interventions for borderline personality disorder. Cochrane Database Syst Rev 2010. • Sheridan M, Fox N, Zeanahe MH, McLaughlin KA, Nelson Ch. Variation in neural development as a result of exposure to institutionalization early in childhood. Proc Natl Acad Sci (USA) 2012; 109(32): 12927–12932. • Soloff PH, Meltzer C, Becker C, Greer P, Kelly T, Constantine D. Impulsivity and prefrontal hypometabolism in borderline personality disorder. Psychiatry Res 2003; 123(3): 153-163. Teicher M, Anderson C, Polcaria, A. Childhood maltreatment: altered network centrality of cingulate, precuneus, temporal pole and insula. Biol Psychiatry 2014; 76(4): 297–305. • Teicher MH, Ohashi K, Lowen SB; Polcari A. Fitzmaurice GM. Mood dysregulation and affective instability in emerging adults with childhood maltreatment: an ecological momentary assessment study. J Psychiatr Res 2015; 70: 1–8. • Teicher M, Samson J, Anderson C, Ohashi K. The effects of childhood maltreatment on brain structure, function and connectivity. Nat Rev Neurosci 2016; 17(10): 652-666. • Tebartz van Elst L, Thiel T, Hesslinger B, Lieb K, Bohus M, Hennig J, Ebert D. Subtle prefrontal neuropathology in a pilot magnetic resonance spectroscopy study in patients with borderline personality disorder. J Neuropsychiatry Clinical Neurosci 2001; 13(4): 511–4. • Terbartz van Elst L, Hesslinger B, Thiel T, Geiger E, Haegele K, Lemieux L, Lieb K, Bohus M, Henning J, Ebert D. Frontolimbic brain abnormalities in patients with borderline personality disorder. Biol Psychiatry 2003; 54 (2): 163-171. • Torgersen S, Myers J, Reichborn-Kjennerud T, Røysamb E, Kubarych TS, Knedler, K. The heritability of cluster B personality disorders assessed both by personal Interview and questionnaire. J Pers Disord 2012; 26(6): 848–866. • Treede RD, Kenshalo D, Gracely RH, Jones A. The cortical representation of pain. Pain 1999; 79 (2-3): 105-111. • Völlm B, Zhao L, Richardson P, Clark L, Deakin J, Williams S, Dolan M. A voxel-based morphometric MRI study in men with borderline personality disorder: preliminary findings. Crim Behav and Ment Health 2009; 19(1): 64-72. • Wallom H., Young, L. The neural mechanisms and neural circuitry of the pair bond formation. Nat Rev Neurosciens 2018; 19(11): 643-654. • Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lépine JP, Newman SC, Rubio – Stipec M, Wells JE, Wickramaratne PJ, Wittchen H, Yeh EK. Cross-national epidemiology of major depression and bipolar disorder. JAMA 1996; 276(4): 293-299. • Widiger TA, Mullins-Sweatt SN. Modelos categoriales y dimensionales de los trastornos de la personalidad. En: Oldman JM, Skodol AE, Bender DS, editores. Tratado de los Trastornos de la Personalidad. Barcelona: Elsevier Masson;2007 p.37-55. • Yuste R. From the neuron doctrine to neural networks. Nat Rev Neurosci 2015; 16(8): 487-497. • Zanarini MC, Frankenburg FR, Hennen J, Bradford RD, Silk K. The McLean study of adult development (MSAD): overview and implications of the first six years of prospective follow-up. J Pers Disord 2005; 19(5): 505–523. • Zanarini M, Frankenburg F, DeLuca C, Hennen J, Khera G, Gunderson J. The pain of being borderline: dysphoric states specific to borderline personality disorder. Harv Rev Psychiatry 1998; 6(4): 201-207. • Zanarini MC, Frankenburg, FR, Bradford Reich B, Fitzmaurice G. Attainment and stability of sustained symptomatic remission and recovery among patients with borderline personality disorder and axis II comparison subjects: a 16-year prospective follow -up study. Am J Psychiatry 2012; 169(5): 476-483. • Zhang Y, Wang D, Johnson AD, Papp AC, Sadée W. Allelic expression imbalance of human mu-opioid receptor (OPRM1) caused by variant A118G. J Biol Chem 2005; 280(38): 32618–32624. • Zieher, L Cohen, D. Neurociencia de la neurona a la mente. Buenos Aires: Editorial Sciens 2017; pp. 43-60. 24 // EDITORIAL SCIENS

Biblioteca

Av. García del Río 2585 Piso 12 A - C.A.B.A
+54 11 2092 1646 | info@sciens.com.ar

Editorial Sciens, Todos los Derechos Reservados 2015